Business News


FranklinResources-073014-lg.jpgFranklin Resources Inc. on Wednesday reported a 5 percent increase in profit for the third quarter from last year on higher revenues that were partly offset by increases in operating expenses and taxes. Both revenue and earnings per share for the quarter missed analysts' expectations. However, the company's assets under management increased 13 percent from last year.
More

Sanofi And Regeneron: 9 Phase 3 ODYSSEY Trials Of Alirocumab Met Primary Goal



French drug maker Sanofi (SNYNF, SNY) and U.S.-based Regeneron Pharmaceuticals, Inc. (REGN) announced Wednesday that nine new Phase 3 ODYSSEY trials of alirocumab in people with hypercholesterolemia met their primary efficacy endpoint. According to the companies, the primary goal was of a greater...
More

Latest News
More

Phillips 66 Q2 Profit Down 10% On Lower Refining Earnings


Oil refiner and chemical maker Phillips 66 (PSX) on Wednesday reported a 10 percent decrease in profit for the second quarter from last year, reflecting lower earnings at its refining as well as marketing and specialties segments. In addition, the prior-year quarter's results included a gain on asset...
More
GDPchart-073014.jpg

U.S. Economy Shows Stronger Than Expected Rebound In Q2


After reporting a notable contraction in U.S. economic activity in the first quarter, the Commerce Department released a report on Wednesday showing that gross domestic product rebounded by more than anticipated in the second quarter.

Belgium Q2 GDP Up 1% On Year Vs. 1.2% In Q1

More

Boralex Subsidiary Acquires Calmont 14 MW Wind Power Project In Midi-Pyrénées Region In France


Home BancShares Signs Definitive Deal For Home To Acquire Broward

More

Dorman Products Inc. (DORM) Has Dropped To A New Low After Weak Q2 Report


Dorman Products Inc. (DORM) reported second quarter EPS of $0.64 Wednesday morning, up from $0.53 a year ago. The consensus estimate was for EPS of $0.65. Dorman Products gapped open sharply lower Wednesday and is now down 5.12 at $43.20, with volume at over a 5-month high. The stock has plunged to...
More

ContraFect Prices IPO At $6.00 Per Unit


ContraFect Corp. (CFRXU), a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious diseases, announced the pricing of its initial public offering of 6 million units priced at $6.00 per unit for total gross proceeds of $36 million. The offering was priced...
More

Barrett Business Services Q2 14 Earnings Conference Call At 12:00 PM ET


Barrett Business Services Inc. (BBSI) will host a conference call at 12:00 PM ET on July 30, 2014, to discuss Q2 14 earnings results. To access the live webcast log on to www.barrettbusiness.com To listen to the call, dial 1-888-430-8691 (US) or 1-719-325-2376 (International), Conference ID: 3575137. For...
More